In recent years, considerable interest has been directed towards the role of neurotransmitters in various types of brain dysfunctions, including cerebral ischemia1), brain tumor2) and hydrocephalus3). There are increasing experimental and clinical evidences that disturbances in the metabolism of central monoamines play an important role in the pathogenesis of hydrocephalus, but the clinical diagnostic and therapeutic implications from the view point of neurotransmitters remain to be established.
In this work, we tried to analyze and accumulate data about patients with ventricular dilatation which were studied from the view point of the metabolic changes of ventricular CSF amine metabolites.
Twenty five patients with ventricular dilatation which was evaluated by the bifrontal cranioventricular index (CVI) were studied. The data reported by West5) and Chase6) was available for control group.
CVI was calculated as the ratio of the width of the frontal horns of the lateral ventricles and the distance between inner table of the skull of both sides on a CT scan taken pallarel to the OM-line CVI over 0.40 was interpreted as ventricular dilatation.
On the basis of the clinical and neuroradiological evaluation, these patients were divided into three groups; 16 patients with obstructive hydrocephalus (O group), 5 patients with the acute stage of congenital hydrocephalus (C group) and 4 patients with secondary normal pressure hydrocephalus after subarachnoid hemorrhage (N group). Fig. 1 Chromatogram of amine metabolites and 5-HT (after Extraction Procedure)
control group (p<0.02), while HVA levels were significantly lower in N group than in control group (p<0.02). 5 HIAA levels were significantly higher in O group and C group than in control group (p<0.05). HVA levels in O group with marked ventricular dilatation (CVI>0.50) were over 300ng/m/. No relationship was found between HVA levels and CVI in C group, while there was the opposite relationship in N group (Fig.2) .
In obstructive hydrocephalus, elevated HVA and 5 HIAA levels may be caused by alterations or obstruction of the ventricular CSF-outflow pathways.
Reabsorption of amine metabolites is considered to take place in the region of the fourth ventricle (choroid plexus) by active transport7 cases, so we have to accumulate more data. It is also necessary to discuss this pathogenesis from the view point of metabolic analysis, besides CT scan and CT-cisternography.
